Literature DB >> 21189284

Transducin β-like protein 1 recruits nuclear factor κB to the target gene promoter for transcriptional activation.

Sivakumar Ramadoss1, Jiong Li, Xiangming Ding, Khalid Al Hezaimi, Cun-Yu Wang.   

Abstract

Nuclear factor κB (NF-κB) signaling controls a wide range of cellular functions such as tumor progression and invasion by inducing gene expression. Upon stimulation, NF-κB is translocated to the nucleus and binds to its target gene promoters to activate transcription by recruiting transcription coactivators. Although significant progress has been made in understanding NF-κB-mediated transactivation, little is known about how NF-κB is recruited to its target gene promoters. Here, we report that transducin β-like protein 1 (TBL1) controls the expression of NF-κB target genes by directly binding with NF-κB and facilitating its recruitment to target gene promoters. Tumor necrosis factor alpha stimulation triggered the formation of an NF-κB and TBL1 complex and subsequent target gene promoter binding. Knockdown of TBL1 impaired the recruitment of NF-κB to its target gene promoters. Interestingly, analysis of the Oncomine database revealed that TBL1 mRNA levels were significantly higher in invasive breast cancer tissues than in breast adenocarcinoma tissue. Consistently, TBL1 knockdown significantly reduced the invasive potential of breast cancer cells by inhibiting NF-κB. Our results reveal a new mechanism for the regulation of NF-κB activation, with important implications for the development of novel strategies for cancer therapy by targeting NF-κB.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21189284      PMCID: PMC3067816          DOI: 10.1128/MCB.00576-10

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

1.  NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.

Authors:  Margit A Huber; Ninel Azoitei; Bernd Baumann; Stefan Grünert; Andreas Sommer; Hubert Pehamberger; Norbert Kraut; Hartmut Beug; Thomas Wirth
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

2.  Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth.

Authors:  H Nakshatri; P Bhat-Nakshatri; D A Martin; R J Goulet; G W Sledge
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

3.  Direct ubiquitination of beta-catenin by Siah-1 and regulation by the exchange factor TBL1.

Authors:  Yoana N Dimitrova; Jiong Li; Young-Tae Lee; Jessica Rios-Esteves; David B Friedman; Hee-Jung Choi; William I Weis; Cun-Yu Wang; Walter J Chazin
Journal:  J Biol Chem       Date:  2010-02-24       Impact factor: 5.157

Review 4.  Regulation of NF-kappaB by atypical activators and tumour suppressors.

Authors:  N D Perkins
Journal:  Biochem Soc Trans       Date:  2004-12       Impact factor: 5.407

5.  TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB.

Authors:  C Y Wang; M W Mayo; A S Baldwin
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

6.  Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.

Authors:  M A Sovak; R E Bellas; D W Kim; G J Zanieski; A E Rogers; A M Traish; G E Sonenshein
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

7.  SMRT derepression by the IkappaB kinase alpha: a prerequisite to NF-kappaB transcription and survival.

Authors:  Jamie E Hoberg; Fan Yeung; Marty W Mayo
Journal:  Mol Cell       Date:  2004-10-22       Impact factor: 17.970

8.  IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a.

Authors:  Mickey C-T Hu; Dung-Fang Lee; Weiya Xia; Leonard S Golfman; Fu Ou-Yang; Jer-Yen Yang; Yiyu Zou; Shilai Bao; Norihisa Hanada; Hitomi Saso; Ryuji Kobayashi; Mien-Chie Hung
Journal:  Cell       Date:  2004-04-16       Impact factor: 41.582

9.  Recruitment of N-CoR/SMRT-TBLR1 corepressor complex by unliganded thyroid hormone receptor for gene repression during frog development.

Authors:  Akihiro Tomita; Daniel R Buchholz; Yun-Bo Shi
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

10.  Fusion protein of retinoic acid receptor alpha with promyelocytic leukemia protein or promyelocytic leukemia zinc finger protein recruits N-CoR-TBLR1 corepressor complex to repress transcription in vivo.

Authors:  Akihiro Tomita; Daniel R Buchholz; Keiko Obata; Yun-Bo Shi
Journal:  J Biol Chem       Date:  2003-06-05       Impact factor: 5.157

View more
  15 in total

1.  Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.

Authors:  Ping Yang; Linlang Guo; Zhijian J Duan; Clifford G Tepper; Ling Xue; Xinbin Chen; Hsing-Jien Kung; Allen C Gao; June X Zou; Hong-Wu Chen
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

2.  Exchange Factor TBL1 and Arginine Methyltransferase PRMT6 Cooperate in Protecting G Protein Pathway Suppressor 2 (GPS2) from Proteasomal Degradation.

Authors:  Jiawen Huang; M Dafne Cardamone; Holly E Johnson; Mathieu Neault; Michelle Chan; Z Elizabeth Floyd; Frédérick A Mallette; Valentina Perissi
Journal:  J Biol Chem       Date:  2015-06-12       Impact factor: 5.157

3.  Signaling between transforming growth factor β (TGF-β) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis.

Authors:  Xiangming Ding; Serk In Park; Laurie K McCauley; Cun-Yu Wang
Journal:  J Biol Chem       Date:  2013-02-27       Impact factor: 5.157

4.  Histone demethylase KDM6B promotes epithelial-mesenchymal transition.

Authors:  Sivakumar Ramadoss; Xiaohong Chen; Cun-Yu Wang
Journal:  J Biol Chem       Date:  2012-11-14       Impact factor: 5.157

5.  A signal transducer and activator of transcription 3·Nuclear Factor κB (Stat3·NFκB) complex is necessary for the expression of fascin in metastatic breast cancer cells in response to interleukin (IL)-6 and tumor necrosis factor (TNF)-α.

Authors:  Marylynn Snyder; Jianyun Huang; Xin-Yun Huang; J Jillian Zhang
Journal:  J Biol Chem       Date:  2014-09-11       Impact factor: 5.157

Review 6.  An overview of gene therapy in head and neck cancer.

Authors:  Amit Bali; Deepika Bali; Ashutosh Sharma
Journal:  Indian J Hum Genet       Date:  2013-07

7.  Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.

Authors:  S Ramadoss; G Guo; C-Y Wang
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

8.  Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells.

Authors:  W Fiskus; S Sharma; S Saha; B Shah; S G T Devaraj; B Sun; S Horrigan; C Leveque; Y Zu; S Iyer; K N Bhalla
Journal:  Leukemia       Date:  2014-12-08       Impact factor: 11.528

9.  Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma.

Authors:  Xian-Cheng Zeng; Fo-Qiu Liu; Rong Yan; Hui-Min Yi; Tong Zhang; Guo-Ying Wang; Yang Li; Nan Jiang
Journal:  Mol Cancer       Date:  2014-12-10       Impact factor: 27.401

10.  Inhibition of IKK/NF-κB Signaling Enhances Differentiation of Mesenchymal Stromal Cells from Human Embryonic Stem Cells.

Authors:  Peng Deng; Chenchen Zhou; Ruth Alvarez; Christine Hong; Cun-Yu Wang
Journal:  Stem Cell Reports       Date:  2016-03-10       Impact factor: 7.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.